Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
62 Cards in this Set
- Front
- Back
Glucose important because?
|
precursor for synthesis or lipids, amino acids, nucleic acids
|
|
Body requires how much glucose?
|
190 mg glucose/day
|
|
Metabolic syndrome can lead to?
|
CV disease
Neuropathy Nephropathy Retinopathy Hyperlipidemias Peripheral vascular disease |
|
Diagnosis of DM?
|
Polyuria
Polydipsia Weight loss |
|
Blood glucose levels for DM?
|
Random blood glucose > 200mg/dL
Fasting glucose >126 mg/dL |
|
How many types of diabetes?
|
4
|
|
Percentages of 1 vs 2?
|
10% 1
90% 2 |
|
Type 3 due to?
|
secondary factors, decrease insulin in CNS in AD
|
|
Type 4 DM?
|
Gestational diabetes
|
|
Risk factors for DM1?
|
genetic
viruses |
|
Risk factors for DM2?
|
Ethnicity
Obesity Life style |
|
Cell types in pancreas?
|
Alpha, Beta, Delta, PP
|
|
Alpha cell percentage? function?
|
20%, mobilizes feul via gluconeogenesis, glycogenolysis
|
|
Alpha cell products?
|
Glucagon
|
|
Beta cell percentage? function?
|
75%
Promotes feul storage and growth |
|
Beta cell products?
|
Insulin
C-peptide Amylin |
|
Delta cell percentage? function?
|
3-5%
Inhibits secretory cells |
|
Delta cell products?
|
Somatostatin
|
|
Somatostatin does what?
|
inhibitory
|
|
F cell (PP) function?
|
factilitate digestive processes
|
|
DM1 is a __ disease causing loss of?
|
autoimmune disease causing loss of beta cells
|
|
_% of DM1 have antibodies to?
|
80% have antibodies to islet cell antigens
|
|
Proinsulin converted to what? where?
|
To Insulin and C-peptide in golgi
|
|
Insulin stored in? as?
|
Stored in beta cells as 6 insulines with 2 zinc
|
|
C-peptide is?
|
used as an index of insulin secretion, no known function
|
|
Degradation of insulin via?
|
Hydrolysis of disulfide bonds and then proteolusis
|
|
Mechanism of insulin release?
|
pancreas exposed to increased glucose which binds Glut-2 and then internalized to ATP, which will close ATP-dependent K channels, decreasing the K flow outward to depolarize the cell, opening Ca channels. Increased Calcium stimulates exocytosis or insulin
|
|
Mechanism of insulin Action?
|
Stimulates glucose uptake into target tissues to initiates phosphorylation cascade and translocates glucose transporters to cell surface
|
|
Glucose enters cell via?
|
Facilitated diffusion
|
|
How many GLUT transporters?
|
5
|
|
GLUT 1 transporter located?
|
in all tissues
|
|
GLUT 1 function?
|
basal uptake of glucose, transport across BBB
|
|
GLUT 2 located?
|
Beta cells of pancreas
|
|
GLUT 2 function?
|
regulation of insulin release
|
|
GLUT 3 located?
|
Brain, kidney
|
|
GLUT 3 function?
|
uptake into neurons
|
|
GLUT 4 located?
|
Muscle, adipose
|
|
GLUT 4 function?
|
insulin mediated glucose uptake
|
|
GLUT 5 located?
|
gut, kidney
|
|
GLUT 5 function?
|
absorption of fructose
|
|
Effect of insulin in liver?
|
Stimulates: storage as glycogen, conversion to fatty acids, VLDL and adipose
Inhibits: Glycogenolysis, Gluconeogenesis |
|
Effect of insulin on skeletal muscle?
|
Stimulates: storage of glycogen and amino acids
Inhibits: Protein degradation |
|
Effect of insulin on adipose tissue?
|
Stimulates: Storage of fatty acids
Inhibits: conversion of TGs to fatty acids |
|
Kinetic profile of NPH altered by?
|
Adding protamine
|
|
Insulin origin?
|
Beef, pork
Human, recombinant in E.Coli or yeast |
|
E. Coli:
Yeast: |
E Coli - Humulin
Yeast - Novolin |
|
Types of insulin:
|
Ultra short acting
Short acting Intermediate Ultra long acting |
|
Ultra short acting insulins:
|
Lispro
Aspart Glulisine |
|
Ultra short acting insulins onset? duration?
|
onset 15 mins, lasts 4 hours
|
|
Short acting insulins?
|
Regular
|
|
Short acting insulin onset? duration?
|
onset in .5 to 1 hour
duration 5 to 7 hours |
|
Intermediate insulin?
|
NPH
|
|
Intermediate insulin onset? duration?
|
onset 1 to 3 hours
duration 18 to 24 hours |
|
Long acting insulin
|
Glargine
Detemir |
|
Long acting onset? duration?
|
onset 2 to 4 or 5 to 6 hours
duration ~24 hours |
|
insulin delivery options
|
injection
portable pen subcutaneous infusion inhaled aerosolized sublingual |
|
Indications for insulin:
|
All type 1
Pregnant diabetics, gestational DM DM2 not controlled Hyperkalemia |
|
Drugs that decrease effect of insulin?
|
Oral contraceptives
Corticosteroids Dobutamine Epinephrine Naicin Smoking Thiazides Thyroid hormone |
|
Drugs that increase effect of insulin?
|
Alcohol
Alpha-blockers Anabolic steroids Beta-blockers MAOI |
|
Complications of insulin?
|
Hypoglycemia
Immunopathology Lipodystrophy |
|
Goals of insulin therapy
|
Maintain blood glucose in acceptable range
Prevent microvascular complications |
|
ADAs Goals:
Fasting Postprandial A1C |
Fasting 80-120
Postprandial 100-140 A1C <7 |